Ginsenoside-Rd for Acute Ischemic Stroke

NCT00591084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: ginsenoside-Rd 10 mg
DRUG: placebo
DRUG: ginsenoside-Rd 20mg

Sponsor

Xijing Hospital